Novo Nordisk
10 incidents / jurisdictions: European Union, United Kingdom, United States / sum of amounts reported: USD 92.7 m
| Date | Jurisdiction | Outcome | What happened (source) | Damages / settlement / fine |
|---|
| 2025 | European Union | Industry-code breach ruling | In 2025, the Irish Health Products Regulatory Authority identified several non-compliances relating to advertising rules in educational and training materials in 2021 and 2022. A May 2021 teaching gui Wikipedia: Novo Nordisk（Legal issues） | — |
| 2024 | United States | Filed / under investigation | In February 2024, the United States Judicial Panel on Multidistrict Litigation ordered that 55 lawsuits pending in federal courts be consolidated into a multidistrict litigation. The majority of the c Wikipedia: Novo Nordisk（Legal issues） | — |
| 2023 | United Kingdom | Industry-code breach ruling | In March 2023, Novo was suspended from the ABPI for a period of two years, for engaging in misleading marketing practices that amounted to "bribing health professionals with inducement to prescribe". Wikipedia: Novo Nordisk（Legal issues） + 1 more reports | — |
| 2023 | United States | Filed / under investigation | In August 2023, one of the first lawsuits was filed alleging that Novo's Ozempic and Eli Lilly 's Mounjaro (tirzepatide) caused severe gastrointestinal side effects, including gastroparesis . The laws Wikipedia: Novo Nordisk（Legal issues） | — |
| 2023 | United States | Filed / under investigation | In September 2023, the law firm Motley Rice filed a lawsuit on behalf of a Pennsylvania woman who had been taking weight-loss drug Wegovy. The lawsuit alleges that the plaintiff experienced severe sto Wikipedia: Novo Nordisk（Legal issues） | — |
| 2017 | United States | Settlement | In September 2017, Novo agreed to pay $58.7 million to end a United States Department of Justice probe into the lack of FDA disclosure to doctors about the cancer risk for their diabetic drug, Victoza Wikipedia: Novo Nordisk（Legal issues） + 2 more reports | $58.7 million / $58 Million / $58.65 million / $12.15 million |
| 2013 | European Union | Fine / administrative sanction | In 2013, Novo had to pay back 3.6 kr. billion to the Danish tax authorities due to transfer mispricing. Wikipedia: Novo Nordisk（Legal issues） | — |
| 2011-06-10 | United States | Settlement | Danish Pharmaceutical Novo Nordisk to Pay $25 Million to Resolve Allegations of Off-Label Promotion of Novoseven U.S. Department of Justice | $25 Million |
| 2010 | United Kingdom | Industry-code breach ruling | In 2010, Novo breached the code of conduct for Association of the British Pharmaceutical Industry (ABPI), by failing to provide information about side-effects of Victoza and by promoting Victoza prior Wikipedia: Novo Nordisk（Legal issues） | — |
| 2009-05-11 | United States | Fine / administrative sanction | Novo Nordisk Agrees to Pay $9 Million Fine in Connection with Payment of $1.4 Million in Kickbacks Through the United Nations Oil-for-food Program U.S. Department of Justice | $9 Million |
Amounts are extracted mechanically from headlines and summaries and kept only when Jev confirms they are paid by the company. The same case reported by several articles may be counted more than once, so totals are indicative. Check the sources.